News
A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...
The immunotherapy, which involves using white blood cells to attack foreign cells, has been heralded as ‘groundbreaking’ by ...
A LIVING cancer drug has been proven to work against solid tumours for the first time. Immune-boosting CAR-T therapy removes ...
Gut bacteria produce metabolites that influence drug metabolism and affect immune cell function, potentially enhancing or ...
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results